Funded Health Care Startups in Switzerland
Across the 50 most recent health care rounds in Switzerland shown here, the only disclosed round above $50M is CeQur’s $100M (Series E) on 2026-06-09; the…
Across the 50 most recent health care rounds in Switzerland shown here, the only disclosed round above $50M is CeQur’s $100M (Series E) on 2026-06-09; the next-largest disclosed amounts sit far below that, including Neo Medical’s $69M (Series B) on 2024-09-17 and SkyCell’s $59M (Series D) on 2024-06-25. Another outlier pattern is how often the amount is not disclosed: 18 of 50 rows list “undisclosed” amounts, and a further 17 of 50 are labeled “Series Unknown,” making comparability heavily constrained by disclosure rather than by stage.
Geographically, the city-level signal concentrates in Geneva and Zurich: Geneva appears repeatedly (e.g., UNBOOUND $130K on 2026-04-22; Terapet $3M on 2026-04-10; Transform Health $490K on 2023-12-20), while Zurich is also frequent (e.g., CeQur in Horw/Luzern is the large exception, and Zurich-based entries include Resmonics $210K on 2025-01-16 and SkyCell $59M on 2024-06-25). Temporally, the list spans 2023-03-02 to 2026-06-23, with the most recent entry MoleSense in Lausanne (Vaud) at $110K on 2026-06-23.
Most recent rounds
50 of 7222 more funded startups
This page shows the 50 most recent rounds (back to Mar 2023). The full 72-company history for this listing is available on a paid plan.
Unlock all 72 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What’s the largest disclosed round in this Switzerland health care list, and how different is it from the rest of the disclosed amounts?
CeQur’s $100M (Series E) on 2026-06-09 is the only disclosed amount above $50M in the 50-row view; the next-largest disclosed amounts are $69M for Neo Medical (Series B) on 2024-09-17 and $59M for SkyCell (Series D) on 2024-06-25.
How much does disclosure uncertainty limit comparisons in this dataset?
Of the 50 rows, 18 list “undisclosed” amounts (for example, vVardis on 2026-04-27 and Spirecut on 2024-03-26). Stage labels are also frequently missing: 17 rows are marked “Series Unknown” (e.g., MoleSense on 2026-06-23 and Calmea on 2026-06-08).
Is there a geographic concentration around specific Swiss cities (beyond country-level)?
Yes. Geneva appears across multiple dates and sizes, including UNBOOUND in Geneva at $130K on 2026-04-22 and Transform Health in Geneva at $490K on 2023-12-20; Zurich also recurs with entries such as Resmonics at $210K on 2025-01-16 and SkyCell at $59M on 2024-06-25.
What does the stage mix suggest when stage names are present versus missing?
When stage names are provided, large rounds are still relatively uncommon: major disclosed examples include CeQur (Series E) at $100M on 2026-06-09 and Neo Medical (Series B) at $69M on 2024-09-17. But missing stage classification is common, with 17 of 50 rows labeled “Series Unknown,” such as Calmea ($190K) on 2026-06-08 and Vivent ($9M) on 2025-11-20.
Which entries fall at the most recent edge of the time window, and are they unusually large or small?
The newest round shown is MoleSense (Lausanne) on 2026-06-23 at $110K (Series Unknown). Other late-2026 entries cluster around smaller disclosed sizes—e.g., Calmea at $190K on 2026-06-08 and UNBOOUND at $130K on 2026-04-22—while the standout late-2026 disclosed maximum remains CeQur at $100M on 2026-06-09.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.